Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.
Dr. Tom Imperiale in American Society of Gastrointestinal Endoscopy

Regenstrief research scientist Thomas F. Imperiale, M.D., has been awarded the honorable distinction of Fellow in the American Society for Gastrointestinal Endoscopy. The distinction recognizes his significant contributions to the field of endoscopy as well as his dedication to patient care, research, teaching and service.

Dr. Imperiale is an internationally respected health services researcher and a clinical gastroenterologist. During his research career, he has focused on developing and testing colorectal cancer screening strategies based on risk factors. His findings have been published in highly regarded journals including the New England Journal of Medicine, Journal of the American Medical Association, Annals of Internal Medicine and Gastroenterology.

In addition to his role at Regenstrief, Dr. Imperiale is a core investigator at the Health Services Research and Development Center for Health Information and Communication at Richard L. Roudebush VA Medical Center. He is also the first person to be named the Lawrence Lumeng Professor of Gastroenterology and Hepatology at the Indiana University School of Medicine.

Dr. Imperiale has mentored more than 50 medical residents, faculty, and fellows. He is also a fellow in the American Gastroenterological Association and a member of the Association of American Physicians.

The American Society for Gastrointestinal Endoscopy is a professional organization dedicated to advancing patient care and digestive health. It provides endoscopic education and training and fosters research. All of its 15,000 members have highly specialized training in endoscopic procedures of the digestive tract.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org

Related News

Jan 21, 2022 • News
Three doses of mRNA COVID-19 vaccines are very effective in protecting against emergency department visits and hospitalizations associated with Omicron and Delta variations of the virus
New CDC study provides strong evidence that vaccines successfully combat severe disease A nationwide study from the Centers for Disease Control and Prevention (CDC) has found that mRNA booster shots (either Pfizer or Moderna) are 82 percent effective in protecting against COVID-19 Omicron variant-associated emergency department (ED) visits and 90 percent effective in protecting against…
Continue Reading >
Jan 13, 2022 • News
Intervention leads to increase in primary care screenings for older adults
Education-system solution designed to integrate geriatrics into primary care Falls and dementia are some of the most common syndromes affecting the health of older adults, but many primary care physicians are not specifically trained to screen for them. The Indiana Geriatrics Education and Training Center (Indiana GETC) created a successful intervention combining education and workflow…
Continue Reading >